Evidence map›Paper›PMID 35194197›Full record

ArticleEuropean journal of clinical nutrition2022

Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study.

Carolina Donat-Vargas, Ángel Guerrero-Zotano, Virginia Lope, Begoña Bermejo, Ana Casas, José Manuel Baena-Cañada, Silvia Antolín, Pedro Sánchez-Rovira, Antonio Antón, José Ángel Garcia-Saénz and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 18 institutions in 2 countries.

Carolina Donat-VargasIMDEA-Food Institute. CEI UAM+CSIC, Madrid, Spain.ORCID http://orcid.org/0000-0002-4523-4148
Ángel Guerrero-ZotanoMedical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain.
Virginia LopeNational Center for Epidemiology, Instituto de Salud Carlos III (ISCII), Madrid, Spain.ORCID http://orcid.org/0000-0002-6986-4021
Begoña BermejoMedical Oncology Unit, Hospital Clínico, Valencia, Spain.
Ana CasasMedical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain.
José Manuel Baena-CañadaMedical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain.ORCID http://orcid.org/0000-0002-8403-9804
Silvia AntolínMedical Oncology Unit, Complejo Hospitalario Universitario A Coruña, Coruña, Spain.
Pedro Sánchez-RoviraMedical Oncology Unit, Hospital Universitario de Jaén, Jaén, España.
Antonio AntónMedical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, España.
José Ángel Garcia-SaénzMedical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain.
Manuel RamosMedical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain.
Montserrat MuñozMedical Oncology Unit, Hospital Clinic i Provincial, Barcelona, Spain.
Ana de JuanMedical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain.
Carlos Jara SánchezMedical Oncology Unit/Departamento Especialidades Médicas, Hospital Universitario Fundación Alcorcón/Universidad Rey Juan Carlos, Madrid, Spain.
José Ignacio ChacónMedical Oncology Unit, Hospital Virgen de la Salud, Toledo, Spain.
Miguel Gil-GilMedical Oncology Unit, Instituto Catalán de Oncología, Hospitalet, Barcelona, Spain.
Raquel Andrés ConejeroMedical Oncology Unit, Hospital Clínico Lozano Blesa, Zaragoza, Spain.
Antonio LlombartMedical Oncology Unit, Hospital Arnau de Vilanova, Valencia, Spain.
Susana BezaresGEICAM Spanish Breast Cancer Group, Madrid, Spain.ORCID http://orcid.org/0000-0003-3075-2265
Nerea Fernández de Larrea-BazNational Center for Epidemiology, Instituto de Salud Carlos III (ISCII), Madrid, Spain.
Beatriz Pérez-GómezNational Center for Epidemiology, Instituto de Salud Carlos III (ISCII), Madrid, Spain.ORCID http://orcid.org/0000-0002-4299-8214
Miguel MartínMedical Oncology Unit, Instituto de Investigación Sanitaria Gregorio Marañón/Universidad Complutense, Madrid, Spain.
Marina PollánNational Center for Epidemiology, Instituto de Salud Carlos III (ISCII), Madrid, Spain. mpollan@isciii.es.ORCID http://orcid.org/0000-0002-4328-1565
Instituto de Salud Carlos III · ESBiomedical Research and Innovation Institute of Cadiz · ESCentro Oncológico de Galicia · ESComplejo Hospitalario de Jaén · ESComplexo Hospitalario Universitario A Coruña · ESFundación Instituto Valenciano de Oncología · ESGEICAM – Spanish Breast Cancer Group · ESHospital Arnau de Vilanova · ESHospital Clínic de Barcelona · ESHospital Clínico San Carlos · ESHospital Clínico Universitario de Valencia · ESHospital Clínico Universitario Lozano Blesa · ESHospital Universitario Miguel Servet · ESHospital Universitario Virgen del Rocío · ESHospital Virgen de la Salud · ESMadrid Institute for Advanced Studies · ESMarqués de Valdecilla University Hospital · ESUniversidad Rey Juan Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Epi-GEICAM study comprises 1017 invasive BC cases matched with controls of similar age (49 ± 9 years) and residence. Diet and OO consumption were collected through a validated food frequency questionnaire. 75% of women referred OO, common (refined) or virgin, as the main fat source. Using conditional logistic regression models, we compared different scenarios of type and frequency of OO consumption, using as reference those women not always using OO for the three culinary practices (seasoning, cooking, and frying) and adding <2 tablespoons (tbsps.) per day during the meal to bread, salad, or dishes. A substantial inverse association was observed in those women always using VOO for the three culinary practices and consuming ≥2 tbsps. of OO per day during meals (adjusted OR, 0.72; 95% CI: 0.51, 1.03; P = 0.07). Potential benefits from OO consumption, at least as regards the protection provided for BC, could be mostly conferred with VOO, and when its consumption is high.

Indexed as

Breast NeoplasmsAdultCase-Control StudiesCookingDietFemaleHumansMiddle AgedOlive OilPlant OilsOlive OilPlant Oils

Identifiers

PMID35194197
OpenAlexW4213166117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.